IBDEI2MU ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44180,2)
 ;;=^5000316
 ;;^UTILITY(U,$J,358.3,44181,0)
 ;;=A54.01^^200^2224^45
 ;;^UTILITY(U,$J,358.3,44181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44181,1,3,0)
 ;;=3^Gonococcal Cystitis & Urethritis,Unspec
 ;;^UTILITY(U,$J,358.3,44181,1,4,0)
 ;;=4^A54.01
 ;;^UTILITY(U,$J,358.3,44181,2)
 ;;=^5000312
 ;;^UTILITY(U,$J,358.3,44182,0)
 ;;=B37.49^^200^2224^12
 ;;^UTILITY(U,$J,358.3,44182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44182,1,3,0)
 ;;=3^Candidiasis Urogenital,Other
 ;;^UTILITY(U,$J,358.3,44182,1,4,0)
 ;;=4^B37.49
 ;;^UTILITY(U,$J,358.3,44182,2)
 ;;=^5000618
 ;;^UTILITY(U,$J,358.3,44183,0)
 ;;=B37.41^^200^2224^11
 ;;^UTILITY(U,$J,358.3,44183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44183,1,3,0)
 ;;=3^Candidal Cystitis & Urethritis
 ;;^UTILITY(U,$J,358.3,44183,1,4,0)
 ;;=4^B37.41
 ;;^UTILITY(U,$J,358.3,44183,2)
 ;;=^5000616
 ;;^UTILITY(U,$J,358.3,44184,0)
 ;;=B37.42^^200^2224^10
 ;;^UTILITY(U,$J,358.3,44184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44184,1,3,0)
 ;;=3^Candidal Balanitis
 ;;^UTILITY(U,$J,358.3,44184,1,4,0)
 ;;=4^B37.42
 ;;^UTILITY(U,$J,358.3,44184,2)
 ;;=^5000617
 ;;^UTILITY(U,$J,358.3,44185,0)
 ;;=A59.03^^200^2224^96
 ;;^UTILITY(U,$J,358.3,44185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44185,1,3,0)
 ;;=3^Trichomonal Cystitis & Urethritis
 ;;^UTILITY(U,$J,358.3,44185,1,4,0)
 ;;=4^A59.03
 ;;^UTILITY(U,$J,358.3,44185,2)
 ;;=^5000349
 ;;^UTILITY(U,$J,358.3,44186,0)
 ;;=E87.6^^200^2224^57
 ;;^UTILITY(U,$J,358.3,44186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44186,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,44186,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,44186,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,44187,0)
 ;;=F52.0^^200^2224^56
 ;;^UTILITY(U,$J,358.3,44187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44187,1,3,0)
 ;;=3^Hypoactive Sexual Desire Disorder
 ;;^UTILITY(U,$J,358.3,44187,1,4,0)
 ;;=4^F52.0
 ;;^UTILITY(U,$J,358.3,44187,2)
 ;;=^5003618
 ;;^UTILITY(U,$J,358.3,44188,0)
 ;;=F52.22^^200^2224^93
 ;;^UTILITY(U,$J,358.3,44188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44188,1,3,0)
 ;;=3^Sexual Arousal Disorder,Female
 ;;^UTILITY(U,$J,358.3,44188,1,4,0)
 ;;=4^F52.22
 ;;^UTILITY(U,$J,358.3,44188,2)
 ;;=^5003621
 ;;^UTILITY(U,$J,358.3,44189,0)
 ;;=F52.8^^200^2224^94
 ;;^UTILITY(U,$J,358.3,44189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44189,1,3,0)
 ;;=3^Sexual Dysfnct Not d/t Substance/Known Physiological Cond
 ;;^UTILITY(U,$J,358.3,44189,1,4,0)
 ;;=4^F52.8
 ;;^UTILITY(U,$J,358.3,44189,2)
 ;;=^5003624
 ;;^UTILITY(U,$J,358.3,44190,0)
 ;;=F52.21^^200^2224^33
 ;;^UTILITY(U,$J,358.3,44190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44190,1,3,0)
 ;;=3^Erectile Disorder,Male (Psychogenic)
 ;;^UTILITY(U,$J,358.3,44190,1,4,0)
 ;;=4^F52.21
 ;;^UTILITY(U,$J,358.3,44190,2)
 ;;=^5003620
 ;;^UTILITY(U,$J,358.3,44191,0)
 ;;=I12.9^^200^2224^55
 ;;^UTILITY(U,$J,358.3,44191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44191,1,3,0)
 ;;=3^Hypertensive Kidney Disease Chronic w/ Stg 1-4
 ;;^UTILITY(U,$J,358.3,44191,1,4,0)
 ;;=4^I12.9
 ;;^UTILITY(U,$J,358.3,44191,2)
 ;;=^5007066
 ;;^UTILITY(U,$J,358.3,44192,0)
 ;;=N04.9^^200^2224^69
 ;;^UTILITY(U,$J,358.3,44192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44192,1,3,0)
 ;;=3^Nephrotic Syndrome w/ Unspec Morphologic Changes
 ;;^UTILITY(U,$J,358.3,44192,1,4,0)
 ;;=4^N04.9
 ;;^UTILITY(U,$J,358.3,44192,2)
 ;;=^5015540
 ;;^UTILITY(U,$J,358.3,44193,0)
 ;;=N02.9^^200^2224^50
 ;;^UTILITY(U,$J,358.3,44193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44193,1,3,0)
 ;;=3^Hematuria w/ Unspec Morphologic Changes,Recurrent & Persistent
